Company intelligence / Profile preview

Glycosyn LLC

Woburn, Massachusetts, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~2
Development stage: Preclinical

Overview

Glycosyn develops proprietary fermentation technologies to produce human milk oligosaccharides at scale. Their products are intended to enhance gut health and immune function in infants, children, and adults. The company targets a range of infectious and chronic diseases but has not publicly disclosed clinical trial results or late-stage development programs.

Therapeutic areas: PulmonologyMetabolic DisordersGastroenterologyInfectious Diseases
Modalities: Human Milk Oligosaccharides (hMOS)Bioactive sugars
Industry: Biotech

Beyond the preview

Go deeper on Glycosyn LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosyn LLC.

Explore the full profile